147 related articles for article (PubMed ID: 7574508)
21. Pharmacokinetics of cefixime in the young and elderly.
Faulkner RD; Bohaychuk W; Lanc RA; Haynes JD; Desjardins RE; Yacobi A; Silber BM
J Antimicrob Chemother; 1988 Jun; 21(6):787-94. PubMed ID: 3410802
[TBL] [Abstract][Full Text] [Related]
22. Penetration and bactericidal activity of cefixime in synovial fluid.
Somekh E; Heifetz L; Dan M; Poch F; Hafeli H; Tanai A
Antimicrob Agents Chemother; 1996 May; 40(5):1198-200. PubMed ID: 8723466
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic profile of cefixime in man.
Faulkner RD; Yacobi A; Barone JS; Kaplan SA; Silber BM
Pediatr Infect Dis J; 1987 Oct; 6(10):963-70. PubMed ID: 3696837
[TBL] [Abstract][Full Text] [Related]
24. Relative bioavailability of three cefixime formulations.
Kees F; Naber KG; Sigl G; Ungethüm W; Grobecker H
Arzneimittelforschung; 1990 Mar; 40(3):293-7. PubMed ID: 2346538
[TBL] [Abstract][Full Text] [Related]
25. [Pharmacokinetic studies on oral antibiotics in pediatrics. I. A pharmacokinetic study on cefixime in pediatrics].
Nakamura H; Iwai N
Jpn J Antibiot; 1991 Sep; 44(9):964-78. PubMed ID: 1960858
[TBL] [Abstract][Full Text] [Related]
26. Comparative bioavailability study of cefixime administered as tablets or aqueous solution.
Montay G; Masala F; Le Roux Y; Le Liboux A; Uhlrich J; Chassard D; Thebault JJ; Roche G; Frydman A
Drugs; 1991; 42 Suppl 4():6-9. PubMed ID: 1725153
[TBL] [Abstract][Full Text] [Related]
27. Bioequivalency of oral suspension formulations of cefixime.
Faulkner RD; Sia LL; Barone JS; Forbes SJ; Silber BM
Biopharm Drug Dispos; 1989; 10(2):205-11. PubMed ID: 2706319
[TBL] [Abstract][Full Text] [Related]
28. Cefixime, in-vitro activity, pharmacokinetics and tissue penetration.
Stone JW; Linong G; Andrews JM; Wise R
J Antimicrob Chemother; 1989 Feb; 23(2):221-8. PubMed ID: 2708180
[TBL] [Abstract][Full Text] [Related]
29. Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin.
Scaglione F; Demartini G; Dugnani S; Arcidiacono MM; Pintucci JP; Fraschini F
Br J Clin Pharmacol; 1999 Mar; 47(3):267-71. PubMed ID: 10215750
[TBL] [Abstract][Full Text] [Related]
30. Clinical pharmacologic aspects of cefixime in dogs.
Lavy E; Ziv G; Aroch I; Glickman A
Am J Vet Res; 1995 May; 56(5):633-8. PubMed ID: 7661460
[TBL] [Abstract][Full Text] [Related]
31. Penetration of cefixime into fibrin clots and in vivo efficacy against Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus.
Bergeron MG; Turcotte A
Antimicrob Agents Chemother; 1986 Dec; 30(6):913-6. PubMed ID: 3545070
[TBL] [Abstract][Full Text] [Related]
32. [Biliary excretion and hepatic disposal of cefixime: experimental and clinical study].
Westphal JF; Brogard JM; Jehl F; Blickle JF; Dorner M; Monteil H
Pathol Biol (Paris); 1992 May; 40(5):538-44. PubMed ID: 1495841
[TBL] [Abstract][Full Text] [Related]
33. Influence of an antacid containing aluminum and magnesium on the pharmacokinetics of cefixime.
Healy DP; Sahai JV; Sterling LP; Racht EM
Antimicrob Agents Chemother; 1989 Nov; 33(11):1994-7. PubMed ID: 2610509
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
[TBL] [Abstract][Full Text] [Related]
35. Concentrations of cefixime in bronchial mucosa and sputum after three oral multiple dose regimens.
Baldwin DR; Andrews JM; Ashby JP; Wise R; Honeybourne D
Thorax; 1990 May; 45(5):401-2. PubMed ID: 2382246
[TBL] [Abstract][Full Text] [Related]
36. [Effect of hepatic failure upon the pharmacokinetics of cefixime].
Singlas E; Lebrec D; Gaudin C; Montay G; Roche G; Taburet AM
Presse Med; 1989 Oct; 18(32):1587-8. PubMed ID: 2530538
[TBL] [Abstract][Full Text] [Related]
37. Liquid-chromatographic determination of five orally active cephalosporins--cefixime, cefaclor, cefadroxil, cephalexin, and cephradine--in human serum.
McAteer JA; Hiltke MF; Silber BM; Faulkner RD
Clin Chem; 1987 Oct; 33(10):1788-90. PubMed ID: 3665031
[TBL] [Abstract][Full Text] [Related]
38. Biliary excretion of cefixime: assessment in patients provided with T-tube drainage.
Westphal JF; Jehl F; Schloegel M; Monteil H; Brogard JM
Antimicrob Agents Chemother; 1993 Jul; 37(7):1488-91. PubMed ID: 8363380
[TBL] [Abstract][Full Text] [Related]
39. Comparative in vitro activity of the new oral cephalosporin cefixime.
Counts GW; Baugher LK; Ulness BK; Hamilton DJ
Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):428-31. PubMed ID: 3137053
[TBL] [Abstract][Full Text] [Related]
40. [Diffusion of ceftriaxone in the renal parenchyma].
Freney J; Mongin-Long D; Meugnier H; Nervi C; Laville M; Zech P; Fleurette J
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):727-9. PubMed ID: 3309805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
